JAMS International ADR Blog

Get the latest updates from our blog:

No annulment of arbitral award in patent license dispute

by David Perkins on 19 May 2016

shutterstock_185570417.jpg

On a reference from the Cour d’Appel de Paris, A.G. Wathelet upholds the primacy of an arbitral award as compatible with Art.101 TFEU in Genentech, Inc. v Hoechst GmbH / Sanofi-Aventis GmbH, Case C-567/14 (Opinion of Advocate General Wathelet: 17 March 2016).

David Perkins finds that for the Advocate Ceneral, the issue turned on the terms of the License Agreement between Hoechst/Sanofi-Aventis and Genetech, and there was nothing in that Agreement which gave rise to infringement of Art.101 TFEU. Nevertheless, if the Opinion is followed by the Court, it is clear that – as a matter of general effect – there is power for a National Court of an EU Member State dealing with a request to set aside or refuse enforcement of an arbitral award to examine whether the Agreement and the effect of the arbitral award infringe Arts.101 and/or 102 TFEU and are, consequently, contrary to public policy.

A full text of the article is published on the Kluwer Arbitration Blog.

Download eBook - Litigation in Review CTA

Topics: International Arbitration, ADR

David Perkins

Written by David Perkins